Roelof Rongen

Insider Reports History

Entity
Individual
Location
C/O Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster, NJ
Signature
/s/ Leanne Kelly, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roelof Rongen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GRI BIO, Inc. Director Stock Option (Right to Buy) 34.5K $52.4K $1.52 Aug 10, 2023 Direct

Insider Reports Filed by Roelof Rongen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRI GRI BIO, Inc. Aug 10, 2023 1 $100K 4 Aug 14, 2023 Director
GRI GRI BIO, Inc. Apr 21, 2023 0 $0 3 Apr 25, 2023 Director